Denali Capital Acquisition Corp.
Status: Closed Deal
U=S+W
W=S@11.50
| IPO Proceeds, $M | $82.50M |
|---|---|
| IPO Date | Apr 7, 2022 |
| CEO | Lei Huang |
| Left Lead | Tiger Brokers |
| IPO Cash in Trust | 102.0% |
| SPAC Tenor | 12 + 3 + 3 + 9 + 9 + 8 |
| IPO Sector | General ▶ |
| IPO Geography | Global |
| Target Company | Semnur Pharmaceuticals |
| Deal Announced | Sep 3, 2024 |
| Deal Size, $M | TBD |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Sep 3, 2025 |
| Amendment Vote | Apr 11, 2025 |
| Closing Date | Sep 22, 2025 |
Formerly DNQAF
SMNR
SMNRW
| Price | $9.00 |
|---|---|
| Last closing price | $9.00 |
| H/L, today | $9.00 / $9.45 |
| Volume, today | 1 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.